The prognostic role of sporadic TP53 mutations in the triple-negative breast cancer group

被引:0
|
作者
Maksimenko, E. [1 ]
Irmejs, A. [1 ]
Berzina, D. [1 ]
Nakazawa-Miklasevica, M. [2 ]
Trofimovics, G. [3 ]
Gardovkis, J. [3 ]
Miklasevics, E. [1 ]
机构
[1] Riga Stradins Univ, Inst Oncol, Riga, Latvia
[2] Riga Stradins Univ, Inst Oncol, Mol Genet Lab, Riga, Latvia
[3] Riga Stradins Univ, Riga, Latvia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S118 / S118
页数:1
相关论文
共 50 条
  • [1] Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer
    Foedermayr, Mathilde
    Sebesta, Miriam
    Rudas, Margaretha
    Berghoff, Anna S.
    Promberger, Regina
    Preusser, Matthias
    Dubsky, Peter
    Gnant, Michael
    Steger, Guenther G.
    Weltermann, Ansgar
    Zielinski, Christoph C.
    Zach, Otto
    Bartsch, Rupert
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 70 - 75
  • [2] Impact of TP53 mutations in Triple Negative Breast Cancer
    Zahi I. Mitri
    Nour Abuhadra
    Shaun M. Goodyear
    Evthokia A. Hobbs
    Andy Kaempf
    Alastair M. Thompson
    Stacy L. Moulder
    npj Precision Oncology, 6
  • [3] Impact of TP53 mutations in Triple Negative Breast Cancer
    Mitri, Zahi, I
    Abuhadra, Nour
    Goodyear, Shaun M.
    Hobbs, Evthokia A.
    Kaempf, Andy
    Thompson, Alastair M.
    Moulder, Stacy L.
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [4] Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
    Luo, Yanli
    Huang, Wentao
    Zhang, Huizhen
    Liu, Guang
    ONCOLOGY LETTERS, 2018, 15 (05) : 6161 - 6170
  • [5] Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
    Dandan Yi
    Lei Xu
    Jiaqi Luo
    Xiaobin You
    Tao Huang
    Yi Zi
    Xiaoting Li
    Ru Wang
    Zaixuan Zhong
    Xiaoqiao Tang
    Ang Li
    Yujian Shi
    Jianmei Rao
    Yifen Zhang
    Jianfeng Sang
    Human Genomics, 13
  • [6] Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
    Yi, Dandan
    Xu, Lei
    Luo, Jiaqi
    You, Xiaobin
    Huang, Tao
    Zi, Yi
    Li, Xiaoting
    Wang, Ru
    Zhong, Zaixuan
    Tang, Xiaoqiao
    Li, Ang
    Shi, Yujian
    Rao, Jianmei
    Zhang, Yifen
    Sang, Jianfeng
    HUMAN GENOMICS, 2019, 13 (1) : 4
  • [7] Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations
    Guerini-Rocco, Elena
    Piscuoglio, Salvatore
    Ng, Charlotte K. Y.
    Geyer, Felipe C.
    De Filippo, Maria R.
    Eberle, Carey A.
    Akram, Muzaffar
    Fusco, Nicola
    Ichihara, Shu
    Sakr, Rita A.
    Yatabe, Yasushi
    Vincent-Salomon, Anne
    Rakha, Emad A.
    Ellis, Ian O.
    Wen, Y. Hannah
    Weigelt, Britta
    Schnitt, Stuart J.
    Reis-Filho, Jorge S.
    JOURNAL OF PATHOLOGY, 2016, 238 (05): : 677 - 688
  • [8] TP53 and/or BRCA1 Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer
    Arimura, Akiko
    Sakai, Kazuko
    Kaneshiro, Kazuhisa
    Morisaki, Takafumi
    Hayashi, Saori
    Mizoguchi, Kimihisa
    Yamada, Mai
    Kai, Masaya
    Ono, Mayumi
    Nishio, Kazuto
    Nakamura, Masafumi
    Kubo, Makoto
    CANCERS, 2024, 16 (06)
  • [9] Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
    Kim, Ji-Yeon
    Park, Kyunghee
    Jung, Hae Hyun
    Lee, Eunjin
    Cho, Eun Yoon
    Lee, Kwang Hee
    Bae, Soo Youn
    Lee, Se Kyung
    Kim, Seok Won
    Lee, Jeong Eon
    Nam, Seok Jin
    Ahn, Jin Seok
    Im, Young-Hyuck
    Park, Yeon Hee
    CANCER RESEARCH AND TREATMENT, 2016, 48 (04): : 1338 - 1350
  • [10] TP53 mutation in triple negative breast cancer
    Nikolaidou, A.
    Botsfari, E.
    Goupou, E.
    Rouptsiou, E.
    Iosifidou, R.
    Patakiouta, F.
    VIRCHOWS ARCHIV, 2017, 471 : S302 - S302